Alnylam Pharmaceuticals (ALNY)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:667
% of all portfolios:0.007%
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q3  2023
≡ Dodge & Cox Add 0.50% 12,000 0.00
Q4  2021
≡ Dodge & Cox Add 4.50% 140,000 0.02
Q2  2021
≡ Dodge & Cox Add 28.40% 687,685 0.13
Q4  2020
≡ Lee Ainslie - Maverick Capital Add 1.76% 17,041 0.04
Q1  2020
≡ First Eagle Investment Management Buy 26,500 0.01
Q2  2019
≡ Lee Ainslie - Maverick Capital Add 31.95% 1,025,629 1.08
≡ Dodge & Cox Add 6.32% 190,000 0.02
Q1  2019
≡ Lee Ainslie - Maverick Capital Add 14.50% 406,436 0.50
≡ Dodge & Cox Add 6.89% 193,900 0.03
Q4  2018
≡ Lee Ainslie - Maverick Capital Add 85.44% 1,291,887 1.38
Q3  2018
≡ Lee Ainslie - Maverick Capital Add 121.92% 830,710 0.91
Q2  2018
≡ Lee Ainslie - Maverick Capital Buy 681,354 0.78
Q1  2017
≡ Dodge & Cox Add 1.29% 70,000 0.01
Q4  2016
≡ Dodge & Cox Add 63.44% 2,107,967 0.13
Q3  2016
≡ Dodge & Cox Add 100.01% 1,661,438 0.20
Q2  2016
≡ Dodge & Cox Buy 1,661,330 0.17
Q1  2013
≡ Thomas Russo - Gardner Russo & Quinn Buy 75 0.00

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.